BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23500463)

  • 21. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.
    Wilson PG; Thompson JC; Webb NR; de Beer FC; King VL; Tannock LR
    Am J Pathol; 2008 Dec; 173(6):1902-10. PubMed ID: 18974302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage.
    Li K; Yao W; Zheng X; Liao K
    Cell Res; 2009 Aug; 19(8):1006-17. PubMed ID: 19546885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes.
    Lee HY; Kim SD; Shim JW; Lee SY; Lee H; Cho KH; Yun J; Bae YS
    J Immunol; 2008 Sep; 181(6):4332-9. PubMed ID: 18768891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages.
    Waechter V; Schmid M; Herova M; Weber A; Günther V; Marti-Jaun J; Wüst S; Rösinger M; Gemperle C; Hersberger M
    J Immunol; 2012 Feb; 188(4):1856-67. PubMed ID: 22246625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum amyloid A inhibits RANKL-induced osteoclast formation.
    Oh E; Lee HY; Kim HJ; Park YJ; Seo JK; Park JS; Bae YS
    Exp Mol Med; 2015 Nov; 47(11):e194. PubMed ID: 26563612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum amyloid A inhibits dendritic cell differentiation by suppressing GM-CSF receptor expression and signaling.
    Kim JC; Jung YS; Lee HY; Park JS; Bae YS
    Exp Mol Med; 2017 Aug; 49(8):e369. PubMed ID: 28857084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIF is a regulator of TLR2-induced foam cell formation.
    Huang B; Park DW; Baek SH
    Mol Med Rep; 2016 Oct; 14(4):3329-35. PubMed ID: 27572666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus.
    Li J; Fu Q; Cui H; Qu B; Pan W; Shen N; Bao C
    Arthritis Rheum; 2011 Feb; 63(2):492-502. PubMed ID: 21280004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.
    Chami B; Barrie N; Cai X; Wang X; Paul M; Morton-Chandra R; Sharland A; Dennis JM; Freedman SB; Witting PK
    Int J Mol Sci; 2015 May; 16(5):11101-24. PubMed ID: 25988387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin-triggered lipoxin enhances macrophage phagocytosis of bacteria while inhibiting inflammatory cytokine production.
    Prescott D; McKay DM
    Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G487-97. PubMed ID: 21659618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands.
    Abouelasrar Salama S; Gouwy M; Van Damme J; Struyf S
    Front Endocrinol (Lausanne); 2023; 14():1119227. PubMed ID: 36817589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1.
    Abouelasrar Salama S; De Bondt M; De Buck M; Berghmans N; Proost P; Oliveira VLS; Amaral FA; Gouwy M; Van Damme J; Struyf S
    Front Immunol; 2020; 11():843. PubMed ID: 32477346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells.
    Brandenburg LO; Konrad M; Wruck CJ; Koch T; Lucius R; Pufe T
    J Neurochem; 2010 May; 113(3):749-60. PubMed ID: 20141570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis.
    Lee MS; Yoo SA; Cho CS; Suh PG; Kim WU; Ryu SH
    J Immunol; 2006 Oct; 177(8):5585-94. PubMed ID: 17015746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased stability of phosphatase and tensin homolog by intermedin leading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice.
    Dai XY; Cai Y; Mao DD; Qi YF; Tang C; Xu Q; Zhu Y; Xu MJ; Wang X
    J Mol Cell Cardiol; 2012 Oct; 53(4):509-20. PubMed ID: 22841663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1.
    Christenson K; Björkman L; Tängemo C; Bylund J
    J Leukoc Biol; 2008 Jan; 83(1):139-48. PubMed ID: 17962368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation.
    Missiou A; Rudolf P; Stachon P; Wolf D; Varo N; Aichele P; Colberg C; Hoppe N; Ernst S; Münkel C; Walter C; Sommer B; Hilgendorf I; Nakano H; Bode C; Zirlik A
    Circ Res; 2010 Sep; 107(6):757-66. PubMed ID: 20651286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Amyloid a Promotes Visfatin Expression in Macrophages.
    Wang S; Zhang X; Tan L
    Biomed Res Int; 2016; 2016():4819327. PubMed ID: 27006946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes.
    Koga T; Torigoshi T; Motokawa S; Miyashita T; Maeda Y; Nakamura M; Komori A; Aiba Y; Uemura T; Yatsuhashi H; Ishibashi H; Eguchi K; Migita K
    FEBS Lett; 2008 Mar; 582(5):579-85. PubMed ID: 18243142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.